Detalhe da pesquisa
1.
Efficacy and Safety of Lanreotide Autogel and Temozolomide Combination Therapy in Progressive Thoracic Neuroendocrine Tumors (Carcinoid): Results from the Phase 2 ATLANT Study.
Neuroendocrinology
; 113(3): 332-342, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36044870
2.
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation.
Cancer Immunol Immunother
; 71(4): 865-874, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34462870
3.
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort.
J Transl Med
; 19(1): 270, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34167578
4.
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study.
Oncologist
; 24(6): e327-e337, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30796151
5.
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues.
Gastroenterology
; 155(2): 479-489.e7, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29655834
6.
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC.
Br J Cancer
; 118(6): 820-824, 2018 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29509748
7.
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study.
Pancreatology
; 18(2): 198-203, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29361429
8.
Effect of Age on Melanoma Risk, Prognosis and Treatment Response.
Acta Derm Venereol
; 98(7): 624-629, 2018 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29648671
9.
Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients.
Invest New Drugs
; 34(6): 760-770, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27557783
10.
Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors.
Neuroendocrinology
; 103(6): 806-14, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26789262
11.
Docetaxel plus oral metronomic cyclophosphamide: a phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients.
Cancer
; 120(24): 3923-31, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25111199
12.
Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort.
J Transl Med
; 12: 116, 2014 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24885479
13.
The treatment of advanced melanoma: Current approaches and new challenges.
Crit Rev Oncol Hematol
; 196: 104276, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38295889
14.
TGF-ß mRNA levels in circulating extracellular vesicles are associated with response to anti-PD1 treatment in metastatic melanoma.
Front Mol Biosci
; 11: 1288677, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38633217
15.
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database.
Endocrine
; 84(1): 42-47, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38175391
16.
Epidemiology of Merkel cell carcinoma in Tuscany (Italy), 2006-2021.
Eur J Cancer Prev
; 32(3): 298-300, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719847
17.
The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN Study.
Cancers (Basel)
; 15(7)2023 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37046641
18.
Outcomes in patients with BRAFV600-mutated melanoma and brain metastases at baseline treated with dabrafenib plus trametinib.
Tumori
; 109(6): 537-545, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37417313
19.
Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profile.
Eur J Cancer
; 191: 113246, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37549531
20.
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer.
Clin Cancer Res
; 29(14): 2714-2724, 2023 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37125965